InBody Co.,Ltd (KOSDAQ:041830)
South Korea
· Delayed Price · Currency is KRW 30,050
+350 (1.18%)
Apr 29, 2026, 12:20 PM KST
InBody Co.,Ltd Revenue
In the year 2025, InBody Co.,Ltd had annual revenue of 233.95B KRW with 14.42% growth. InBody Co.,Ltd had revenue of 62.40B in the quarter ending December 31, 2025, with 13.30% growth.
Revenue
233.95B
Revenue Growth
+14.42%
P/S Ratio
1.69
Revenue / Employee
684.06M
Employees
342
Market Cap
396.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 233.95B | 29.48B | 14.42% |
| Dec 31, 2024 | 204.46B | 34.11B | 20.03% |
| Dec 31, 2023 | 170.35B | 10.35B | 6.47% |
| Dec 31, 2022 | 160.00B | 22.17B | 16.08% |
| Dec 31, 2021 | 137.84B | 30.71B | 28.67% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bio Plus | 90.90B |
| i-SENS | 315.44B |
| WON TECH | 156.84B |
| Curexo | 74.53B |
| ToolGen | 1.31B |
| DRTECH | 116.30B |
| T&R Biofab | 26.97B |
| Seegene | 474.23B |